JENNIFER PUGH: Open Payments
NPI 1164757118 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 30 payments from 17 companies in 2025. Trend: 2023 $851 · 2024 $376 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Janssen Biotech, Inc. | 2 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $42 |
| Genmab U.S., Inc. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
Products named: JAKAFI, Nubeqa, FRUZAQLA, ENHERTU, CARVYKTI, Fabhalta, KISQALI, Epkinly.
Industry payments across DE — which companies pay providers there.
